Literature DB >> 15060819

Effect of enamel matrix protein derivative on the attachment, proliferation, and viability of human SaOs(2) osteoblasts on titanium implants.

Frank Schwarz1, Daniel Rothamel, Monika Herten, Anton Sculean, Werner Scherbaum, Jürgen Becker.   

Abstract

The purpose of the present study was to investigate the effects of an enamel matrix protein derivative (EMD) on attachment, proliferation, and viability of human SaOs(2) osteoblasts on titanium implants. A total of 220 sand-blasted and acid-etched (SLA) titanium discs were placed into 24-well culture plates. Before cell inoculation, McCoy's 5A medium (MCM) containing EMD at 25 micro g/ml, 50 micro g/ml, 100 micro g/ml, and 200 micro g/ml was added, and the culture plates were incubated for 30 min. As control, MCM alone was used. Human osteoblast-like cells (SaOs(2)) (2 x 10(4) cells, fourth passage) were suspended in MCM containing 1% penicillin/streptomycin and 10% fetal bovine serum and then inoculated into the well chambers. The medium was changed after 3 days without the addition of EMD. At days 1, 3, and 6, DNA content of the cells was assessed using the CyQuant cell proliferation assay kit, and mitochondrial activity of the cells was measured using a CellTiter-Glo luminescent cell viability assay. The presence of EMD on the titanium discs at days 1 and 6 was evaluated using immunofluorescence stain (IFS) by means of polyclonal antibodies against amelogenin. Additionally, cell morphology was investigated using scanning electron microscopy. Enamel matrix derivative at 25 micro g/ml, 50 micro g/ml, 100 micro g/ml, and 200 micro g/ml demonstrated similar increases in cell proliferation as the control medium at days 3 and 6 ( P>0.05 between groups, respectively). Proliferation, however, appeared to be ameliorated with increasing EMD concentrations. At 25 micro g/ml and 50 micro g/ml, EMD also demonstrated an increase in cell viability similar to the control medium at days 3 and 6 ( P>0.05 between groups, respectively), while EMD at 100 micro g/ml and 200 micro g/ml resulted in statistically significant higher increase in cell viability than in the control medium at day 6 ( P<0.001 between groups, respectively). In all test groups, IFS at day 6 was markedly lower than at day 1. Scanning electron microscopy revealed comparable cell morphology in all groups. Within the limits of the present study, it was concluded that EMD enhanced cell proliferation and viability of human SaOs(2) osteoblasts on SLA titanium implants in a concentration-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15060819     DOI: 10.1007/s00784-004-0259-2

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  33 in total

1.  Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study.

Authors:  A Sculean; P Windisch; G C Chiantella; N Donos; M Brecx; E Reich
Journal:  J Clin Periodontol       Date:  2001-05       Impact factor: 8.728

2.  Effects of enamel matrix protein application on the viability, proliferation, and attachment of human periodontal ligament fibroblasts to diseased root surfaces in vitro.

Authors:  D R Davenport; J M Mailhot; J C Wataha; M A Billman; M M Sharawy; M K Shrout
Journal:  J Clin Periodontol       Date:  2003-02       Impact factor: 8.728

3.  Healing of human intrabony defects following treatment with enamel matrix proteins or guided tissue regeneration.

Authors:  A Sculean; N Donos; P Windisch; M Brecx; I Gera; E Reich; T Karring
Journal:  J Periodontal Res       Date:  1999-08       Impact factor: 4.419

Review 4.  Towards a cellular and molecular understanding of periodontics. Cementogenesis revisited.

Authors:  H C Slavkin
Journal:  J Periodontol       Date:  1976-05       Impact factor: 6.993

5.  Osteoblastic cell attachment to hydroxyapatite-coated implant surfaces in vitro.

Authors:  Y L Chang; C M Stanford; J S Wefel; J C Keller
Journal:  Int J Oral Maxillofac Implants       Date:  1999 Mar-Apr       Impact factor: 2.804

6.  Comparison of MTT and ATP-based assays for the measurement of viable cell number.

Authors:  R D Petty; L A Sutherland; E M Hunter; I A Cree
Journal:  J Biolumin Chemilumin       Date:  1995 Jan-Feb

7.  Enamel matrix derivative prolongs primary osteoblast growth.

Authors:  J Jiang; K E Safavi; L S Spangberg; Q Zhu
Journal:  J Endod       Date:  2001-02       Impact factor: 4.171

8.  Enamel matrix-derived protein stimulates attachment of periodontal ligament fibroblasts and enhances alkaline phosphatase activity and transforming growth factor beta1 release of periodontal ligament and gingival fibroblasts.

Authors:  M T Van der Pauw; T Van den Bos; V Everts; W Beertsen
Journal:  J Periodontol       Date:  2000-01       Impact factor: 6.993

9.  The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity.

Authors:  S P Crouch; R Kozlowski; K J Slater; J Fletcher
Journal:  J Immunol Methods       Date:  1993-03-15       Impact factor: 2.303

10.  Enamel matrix derivative and titanium implants.

Authors:  V Franke Stenport; C B Johansson
Journal:  J Clin Periodontol       Date:  2003-04       Impact factor: 8.728

View more
  9 in total

1.  Human periodontal ligament fibroblasts stimulated by nanocrystalline hydroxyapatite paste or enamel matrix derivative. An in vitro assessment of PDL attachment, migration, and proliferation.

Authors:  Adrian Kasaj; Brita Willershausen; Rüdiger Junker; Stefan-Ioan Stratul; Mirko Schmidt
Journal:  Clin Oral Investig       Date:  2011-06-07       Impact factor: 3.573

2.  Anti-inflammatory effects of EMD in the presence of biomechanical loading and interleukin-1β in vitro.

Authors:  Marjan Nokhbehsaim; Birgit Deschner; Jochen Winter; Christoph Bourauel; Andreas Jäger; Søren Jepsen; James Deschner
Journal:  Clin Oral Investig       Date:  2011-01-12       Impact factor: 3.573

3.  Effects of phosphated titanium and enamel matrix derivatives on osteoblast behavior in vitro.

Authors:  J Anthony Dacy; Robert Spears; William W Hallmon; David G Kerns; Francisco Rivera-Hidalgo; Zoran S Minevski; Carl J Nelson; Lynne A Opperman
Journal:  Int J Oral Maxillofac Implants       Date:  2007 Sep-Oct       Impact factor: 2.804

4.  Premature osteoblast clustering by enamel matrix proteins induces osteoblast differentiation through up-regulation of connexin 43 and N-cadherin.

Authors:  Richard J Miron; Erik Hedbom; Sabrina Ruggiero; Dieter D Bosshardt; Yufeng Zhang; Corinna Mauth; Anja C Gemperli; Tateyuki Iizuka; Daniel Buser; Anton Sculean
Journal:  PLoS One       Date:  2011-08-15       Impact factor: 3.240

5.  The effect of an enamel matrix derivative (Emdogain) combined with bone ceramic on bone formation in mandibular defects: a histomorphometric and immunohistochemical study in the canine.

Authors:  Reza Birang; Mohammad Shah Abouei; Sayed Mohammad Razavi; Peyaman Zia; Ahmad Soolari
Journal:  ScientificWorldJournal       Date:  2012-04-24

6.  Ti-6Al-7Nb promotes cell spreading and fibronectin and osteopontin synthesis in osteoblast-like cells.

Authors:  Thanaphum Osathanon; Kritchai Bespinyowong; Mansuang Arksornnukit; Hidekazu Takahashi; Prasit Pavasant
Journal:  J Mater Sci Mater Med       Date:  2006-07       Impact factor: 4.727

7.  In vitro proliferation of human osteogenic cells in presence of different commercial bone substitute materials combined with enamel matrix derivatives.

Authors:  Christoph Reichert; Bilal Al-Nawas; Ralf Smeets; Adrian Kasaj; Werner Götz; Marcus O Klein
Journal:  Head Face Med       Date:  2009-11-12       Impact factor: 2.151

8.  Effect of enamel matrix derivative on bone formation around intraosseous titanium implant: An experimental study in canine model.

Authors:  Reza Birang; Mohammad Shahabooei; Fatemeh Mashhadiabbas; Mehdi Atabaki; Narges Naghsh; Keikavous Kavosh; Ehsan Birang; Ahmad Mogharehabed
Journal:  Dent Res J (Isfahan)       Date:  2012-11

Review 9.  Injectable Biomaterials for Dental Tissue Regeneration.

Authors:  Håvard Jostein Haugen; Poulami Basu; Mousumi Sukul; João F Mano; Janne Elin Reseland
Journal:  Int J Mol Sci       Date:  2020-05-13       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.